Eiko LifeSciences Limited (BOM:540204)

Market Cap	715.57M +11.8%
Revenue (ttm)	527.07M +39.9%
Net Income	44.96M +113.5%
EPS	3.19 +97.5%
Shares Out	14.35M
PE Ratio	15.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,807
Open	49.03
Previous Close	49.20
Day's Range	48.76 - 49.99
52-Week Range	45.90 - 64.44
Beta	0.10
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About Eiko LifeSciences

Eiko LifeSciences Limited, together with its subsidiary, manufactures and sells specialty and fine chemicals in India and internationally. It operates through Agrochemicals; Oleo Chemicals; Pharmaceuticals; Food Additives; Clinical Research, Development; and Logistics segments. It also offers cosmetic emollients, and flavor and fragrances. In addition, the company is involved in manufacturing, suppling, and exporting of specialty chemicals, fine chemicals, and pharma intermediates; acquiring, manufacturing, leasing, and renting, and managing sh...

• Industry: Industrial Organic Chemicals
• Founded: 1977
• Employees: 7
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540204

Financial Performance

In fiscal year 2026, Eiko LifeSciences's revenue was 527.07 million, an increase of 39.94% compared to the previous year's 376.64 million. Earnings were 44.96 million, an increase of 113.53%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 13, 2026

Data Sources Report a data error